CLINICAL TRIALS PROFILE FOR CHILDREN'S ZYRTEC HIVES RELIEF
✉ Email this page to a colleague
All Clinical Trials for Children's Zyrtec Hives Relief
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00780403 ↗ | Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) | Completed | Merck Sharp & Dohme Corp. | Phase 4 | 2005-08-01 | The primary objective of this study was to determine whether children ages 6-11 years prefer desloratadine RediTabs (2.5 mg) or a marketed competitor (Zyrtec® 5 mg Chewable Tablets). The secondary objectives of this study were to compare acceptance of the two attributes, taste and feeling in the mouth, of desloratadine 2.5 mg RediTabs and Zyrtec® 5 mg Chewable Tablets |
NCT00794378 ↗ | Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day. |
NCT00794794 ↗ | Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-11-01 | This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day. |
NCT02932774 ↗ | Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) | Completed | Pfizer | Phase 4 | 2001-03-01 | The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old. |
NCT02932774 ↗ | Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 4 | 2001-03-01 | The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Children's Zyrtec Hives Relief
Condition Name
Clinical Trial Progress for Children's Zyrtec Hives Relief
Clinical Trial Phase
Clinical Trial Sponsors for Children's Zyrtec Hives Relief
Sponsor Name